STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit
Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout
We haven't written up this one. STAT News has the full story — the link below goes straight to it.